Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Cash from Financing Activities: 2023-2025

Historic Cash from Financing Activities for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to -$26.9 million.

  • Ardent Health's Cash from Financing Activities fell 11468.23% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.2 million, marking a year-over-year decrease of 40123.87%. This contributed to the annual value of $24.6 million for FY2024, which is 12409.69% up from last year.
  • According to the latest figures from Q3 2025, Ardent Health's Cash from Financing Activities is -$26.9 million, which was down 11468.23% from -$25.7 million recorded in Q2 2025.
  • Ardent Health's Cash from Financing Activities' 5-year high stood at $183.4 million during Q3 2024, with a 5-year trough of -$119.8 million in Q2 2024.
  • In the last 3 years, Ardent Health's Cash from Financing Activities had a median value of -$20.5 million in 2024 and averaged -$9.3 million.
  • As far as peak fluctuations go, Ardent Health's Cash from Financing Activities surged by 86712.82% in 2024, and later tumbled by 11468.23% in 2025.
  • Over the past 3 years, Ardent Health's Cash from Financing Activities (Quarter) stood at -$17.9 million in 2023, then fell by 14.48% to -$20.5 million in 2024, then tumbled by 31.47% to -$26.9 million in 2025.
  • Its Cash from Financing Activities stands at -$26.9 million for Q3 2025, versus -$25.7 million for Q2 2025 and -$13.8 million for Q1 2025.